http://www.reportbuyer.com/rss.htmlWelcome to Management / Strategy information research. In this segment you will attain reports on Product Lifecycle Management, Launch Strategies and Pharmaceutical Competitive Intelligence.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/managed_markets_account_management.htmlStudy Overview Today's Market Driven Environment Has Made Performance Assessment of Managed Market Account Executives Complex and Critical. Best Practices, Llc Has Conducted This in-Depth Study to: Identify Common Performance Measurement Practices across Geographies and Hierarchy, Provide Insight into Effective Evaluation of The Function and Determine Measures That Drive Functional Success. Industries Profiled: Pharmaceutical; Health Care; Biotech; Manufacturing; Consumer Products; Media Companies Profiled: Abbott Laboratories; Apria Healthcare; Abraxis; Laboratorios Deramtologicos Darier; Schering-Plough; Q-Med Scandinavia; Bausch & Lomb; Sciele Pharma; Allergan; Celgene; Wyeth Pharmaceuticals; Emd Serono; Astrazeneca; Honeywell; Bayer Schering Ag; Ids; Boehringer Ingelheim; King Pharmaceuticals; Eli Lilly and Company; Lundbeck; Genentech; Skila; Johnson & Johnson; Smith & Nephew; Merck; Ther-Rx; Novo Nordisk; Valeant; Pfizer; Roche; Sanofi-Aventis Project Methodology and Study Objectives Research Was Conducted through Survey and Interviews of Thirty-Two Participants, Sixteen of Whom Were Large Research-Based Pharmaceutical Companies of The World. 04807228309ffbd2752ffdad346f4e9dSat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/developing_managed_care_pull_through_excellence.htmlStudy Overview In Today's Pharmaceutical Marketplace, Companies Not Only Have to Fight to Win Product Placement on Managed Care Formularies but Also to "pull through" The Business and Increase Market Share after A Win. to Benefit from Formulary Wins, Savvy Companies Ensure That Their Sales Forces and Account Management Teams Have The Necessary Skills and Tools to Pull-through Demand for The Favored Products and Increase Sales. This Best Practices, Llc Research Investigates Pull-through Challenges and The Best Practices That Companies Have Developed to Overcome Them. ef89087145dbc6c0e86a0e8342fc178cSat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/best_practices_post_marketing_surveillance_adverse_events_within_u_s.htmlStudy Overview Medical and Scientific Progress Has Been Enormous in The past Decades. However, This Has Also Raised Several Safety Issues Leading to Increased Vigilance on Bio-Pharma Companies by The U. S. 1e4d9c588dd898f6d3b60fde3ddc3390Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/leading_pharmaceutical_companies_comparative_analysis.htmlThis report ranks the world's major pharmaceutical companies according to the following criteria: Sales and market shares. Operating profit and margins. R&D expenditures and percent of sales. bfa83b0dd0fbb215a7db3ae142f03216Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/leading_pharmaceutical_companies_business_organizations_senior_management_profiles.htmlFor each company, the report provides: History of the company's pharmaceutical business evolution, which is important to understanding the corporate culture, management mentality, and strategies. Most recent M&A activity and significant organizational changes. Current organizational structure. fcf1aae339aab650feced987f4b6ab18Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/leading_pharmaceutical_companies_collaborative_arrangements.htmlFor each company, the report analyzes: Major joint venture, distribution, OEM, and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. . c3baebdfeab37216ddeadb563f68eda2Tue, 01 Sep 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/best_practices_internal_communications_regarding_brands_disease_states.htmlStudy Overview When A Promising New Pharmaceutical Product Fails to Meet Expectations, Poor Brand Communications May Be A Contributing Cause. Successful Brand Leaders Today Must Understand How and When to Deliver Complex Key Messages to All Audiences -- Including Internal Stakeholders -- to Realize The Best New Product Results. This Study Is Designed to Help Product Teams Avoid Common Pitfalls in Internal Communications That Can Hinder Brand Performance. 2a070a7331a9081bb9447ec33061e287Tue, 07 Jul 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/innovations_patient_focused_initiatives.htmlStudy Overview with So Much Riding on The Consumers' Acceptance of A Product, IT Is Only Logical to Have in Place Initiatives That Focus on The Unfulfilled Needs of The Consumer Population When Designing Marketing Strategies. The Benefits of Consumer Acceptance Can Span from The Establishment of Name Recognition/Distinction and Reputation to The Generation and Retention of Patient Referrals. Earning This Reputation in The Market Helps to Engender Pride and Trust Not Only amongst Staff, but amongst The Various Stakeholders within The Community as Well. 1a8669302bb940c3856edd3bfa581490Tue, 07 Jul 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/best_practices_recruitment_medical_education_programs.htmlStudy Overview Non-Continuing Medical Education (Non-Cme) Programs, Also Called Promotional Education Programs, Are An Important Tool to Educate and Inform Physicians, Pharmacists, Nurses and Other Healthcare Practitioners. New Regulations and Guidelines regarding Medical Education Programs Have Made IT More Challenging to Recruit Attendees for Both Certified Cme and Non-Cme Programs. This Benchmark Research Project Identifies Emerging Trends in Recruiting Attendees for Medical Education in General and Non-Cme Programs in Particular. faf74b08e06247bfbd08324015167abeTue, 07 Jul 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/clinical_outsourcing_strategy.htmlPerfect the CRO selection and management process - and guarantee trial success Outsourcing is a powerful option for achieving clinical objectives, allowing pharma companies to expand their reach in a therapeutic area, leverage vendors' expertise, and usher a drug through development smoothly - all without overburdening resources. With such benefits come giant obstacles, however. If managed poorly, clinical outsourcing can cause pharma companies to scramble around, regretting decisions and reacting constantly to problems such as trial under-enrollment, numerous change orders, and weak oversight. b52fe46532c45dbd8395ce281044c5d3Tue, 05 May 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/thought_leader_fair_market_value_1.htmlThought leader management teams face many new challenges in today's environment. Academic institutions have implemented new regulations limiting or, in some cases, forbidding their faculty's relationships with drug manufacturers. Individual states continue to call for more transparency of the industry's payments to physicians. e76ba022c22ad87dd213b66516b4111fMon, 02 Feb 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/commercial_insight_community_antibacterials_pipelines_wither_generic_tidal_wave_takes_its_toll.html Datamonitor research points to this sector, beleaguered by patent expiries, barriers to market entry and uptake, becoming increasingly inclement towards branded drugs. Generic incursion has taken a heavy toll on the market at a number of levels. The volume of key brands facing generic competition makes it even harder for remaining products to court large revenues in the community sector. 6a171ea342dcf42ae38f3216ce1a25b9Thu, 01 Jan 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/2009_trendology_u_s_medical_equipment_manufacturing.htmlThe 2009 Trendology report on the U. S. Medical Equipment Manufacturing industry characterizes the industry in three descriptive methods: qualitative analysis, quantitative data and lists of major industry players. eccad2f4f6b1c709f1024e88dbd53b75Thu, 01 Jan 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/evolving_medical_information_call_centers_performance_measurement_process_improvement_1.htmlReinvent Your Medical Information Call Centers: Are your call loads decreasing because customers seek information via new avenues? Do you face info-sharing competition within your own organization? What new areas demand medical information expertise? Evolving Medical Information Call Centers addresses these questions - and more - to give your company the boost needed to correct your call centers' mistakes and evolve the group into new territories. Our study contains real-world data and best practices from top pharmaceutical companies' medical information call center operations. With customers able to find product information on the Internet or from other sources -- and with internal teams encroaching on territory previously owned by medical information groups -- call center leaders now face a number of potentially function-changing challenges. 4929b9362912405e00b7e77769f3efebThu, 01 Jan 2009 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/finding_place_real_time_location_systems_healthcare_strategic_focus.html RTLS, particularly the use of radio frequency identification (RFID), have been a hot topic in healthcare circles recently. Despite the buzz, however, adoption has been slow. This report will examine RTLS in healthcare and determine if the hype around it is deserved. 5128b27d7dcdf8bb80c40b7613d5e20dFri, 12 Dec 2008 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/commercial_insight_rheumatoid_arthritis_anti_tnfs_defend_first_line_biologic_position_despite_competition.html Datamonitor forecasts that total sales for the seven major rheumatoid arthritis markets will grow from $7 billion in 2007 to over $12 billion in 2017. The sustained uptake of anti-TNFs combined with the launch of several new biologic products will drive growth in the short-and mid-term. However, biosimilar entry will cause a small contraction in market value at the end of the forecast period. 910a74cf218395dca436ae75db8da3ffFri, 12 Dec 2008 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/virtual_pharma.htmlMega mergers and the blockbuster model have not delivered the benefits that were claimed for them - growth in the pharmaceutical market has slowed to no more than five per cent and the world's biggest companies are growing slowly, if at all. Against that background pharmaceutical companies, large and small, are looking for new ways to do business - ways that will bring success in a difficult market. For ways to discover and deliver new drugs, to manufacture them more cost-effectively and to sell and market them more successfully. c482f3f64139f2f5a7a9cf077f5ca52cThu, 11 Sep 2008 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/contract_pharma_2008_2023_1.htmlThe revenue for world contract manufacturing business in 2007 was approximately $30bn, with a growth rate of 6% from 2006. The technical expertise and cost savings offered by contract manufacturing organisations (CMOs) make them increasingly essential to you and your organisation. Greater emphasis has been put on European CMOs to leverage low-cost contract manufacturing markets, such as those existing in India and China, to enhance cost efficiency. 9f259747cf4b916bf86e99645618f527Fri, 08 Aug 2008 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/strategic_management_resources_portfolios.htmlAs a company develops its business, resources will always be limited and risk will always be involved. This is especially true for companies operating in the high-risk life science industry. To stay on top of the changing pharmaceutical R&D environment, certain measures must be implemented. 401aae204d9b155d6022232c71fdacaaFri, 08 Aug 2008 12:00:00 GBPharma & Healthcare/Management / Strategyhttp://www.reportbuyer.com/pharma_healthcare/management_strategy/pharmaceutical_competitive_intelligence.htmlSolidify competitive intelligence's presence to optimize decision making: Pharmaceutical competitive intelligence (CI) helps drive decision-making processes across an organization. As a forward-thinking, proactive support function, CI influences business development and brand management, among other areas. CI identifies market risks as well as business growth opportunities. edfd47bb43583634314e0254b3dd5b36Tue, 01 Jul 2008 12:00:00 GBPharma & Healthcare/Management / Strategy